Search publication

Via Vittorio Alfieri,17
Torino (Italy)

FOLLOW US

CONTACTS

+39011.76.51.239
info@adreshe.com

A Cost-Effectiveness Analysis of Mosunetuzumab vs Tisagenlecleucel for Treatment of Third- or Higher-Line (3L+) Relapsed or Refractory (R/R) Follicular Lymphoma (FL) in Italy

Luminari, S., Pinto, A., Puccini, B., D’Arpino, A., Omodeo Salè, E., Bellone, M., Pradelli, L., & Sabinot, A. ClinicoEconomics and outcomes research : CEOR17, 335–348